INTEGRA LIFESCIENCES HLDGS C's ticker is IART and the CUSIP is 457985208. A total of 239 filers reported holding INTEGRA LIFESCIENCES HLDGS C in Q3 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $280,000 | -0.4% | 4,365 | +3.9% | 0.01% | +33.3% |
Q4 2021 | $281,000 | -4.7% | 4,202 | -2.6% | 0.01% | -10.0% |
Q3 2021 | $295,000 | -9.2% | 4,315 | -9.5% | 0.01% | -9.1% |
Q2 2021 | $325,000 | -0.6% | 4,768 | +0.7% | 0.01% | -15.4% |
Q1 2021 | $327,000 | +2.5% | 4,734 | -3.8% | 0.01% | -7.1% |
Q4 2020 | $319,000 | +10.0% | 4,921 | -19.8% | 0.01% | -6.7% |
Q3 2020 | $290,000 | -14.5% | 6,134 | +5.4% | 0.02% | 0.0% |
Q4 2019 | $339,000 | -3.7% | 5,817 | -0.8% | 0.02% | -16.7% |
Q3 2019 | $352,000 | -17.8% | 5,866 | -23.5% | 0.02% | -10.0% |
Q2 2019 | $428,000 | -8.9% | 7,671 | -9.0% | 0.02% | -13.0% |
Q1 2019 | $470,000 | +76.0% | 8,427 | +42.4% | 0.02% | +35.3% |
Q4 2018 | $267,000 | -54.0% | 5,919 | -32.9% | 0.02% | -22.7% |
Q3 2018 | $581,000 | -0.2% | 8,821 | -2.3% | 0.02% | -4.3% |
Q2 2018 | $582,000 | -20.8% | 9,033 | -32.0% | 0.02% | -20.7% |
Q1 2018 | $735,000 | +45.0% | 13,275 | +25.3% | 0.03% | +45.0% |
Q4 2017 | $507,000 | -10.9% | 10,593 | -6.0% | 0.02% | -16.7% |
Q3 2017 | $569,000 | +1.4% | 11,268 | +9.5% | 0.02% | -4.0% |
Q2 2017 | $561,000 | +17.4% | 10,289 | -9.3% | 0.02% | +19.0% |
Q1 2017 | $478,000 | -18.7% | 11,349 | +65.5% | 0.02% | -22.2% |
Q4 2016 | $588,000 | +52.3% | 6,857 | +46.5% | 0.03% | +50.0% |
Q3 2016 | $386,000 | +23.3% | 4,680 | +19.4% | 0.02% | +20.0% |
Q2 2016 | $313,000 | +18.6% | 3,920 | -0.1% | 0.02% | +7.1% |
Q1 2016 | $264,000 | -26.9% | 3,922 | -26.3% | 0.01% | -17.6% |
Q4 2015 | $361,000 | +71.9% | 5,325 | +50.9% | 0.02% | +41.7% |
Q3 2015 | $210,000 | -39.1% | 3,529 | -31.0% | 0.01% | -14.3% |
Q2 2015 | $345,000 | -12.0% | 5,117 | -19.5% | 0.01% | -6.7% |
Q1 2015 | $392,000 | +66.1% | 6,360 | +46.0% | 0.02% | +50.0% |
Q4 2014 | $236,000 | -5.6% | 4,356 | -18.1% | 0.01% | -9.1% |
Q2 2014 | $250,000 | +4.2% | 5,319 | +2.0% | 0.01% | 0.0% |
Q1 2014 | $240,000 | -53.9% | 5,214 | -52.3% | 0.01% | -52.2% |
Q4 2013 | $521,000 | +41.6% | 10,926 | +19.6% | 0.02% | +15.0% |
Q3 2013 | $368,000 | – | 9,137 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VeriStar Capital Management LP | 268,000 | $10,234,920 | 8.72% |
Madison Avenue Partners, LP | 964,667 | $36,840,633 | 5.23% |
Pavadi Capital LLC | 99,999 | $3,818,962 | 4.97% |
KESTREL INVESTMENT MANAGEMENT CORP | 122,450 | $4,676 | 2.96% |
Sapience Investments, LLC | 245,700 | $9,383,283 | 2.26% |
Ellsworth Advisors, LLC | 102,500 | $3,882,700 | 1.38% |
Point72 Europe (London) LLP | 464,462 | $17,737,804 | 1.09% |
COOKE & BIELER LP | 2,714,194 | $103,655,069 | 1.01% |
TANDEM CAPITAL MANAGEMENT CORP /ADV | 75,586 | $2,886,630 | 0.99% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,827 | $43,033,523 | 0.95% |